A carregar...
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients
OBJECTIVE—: CSL112 (apolipoprotein A-I [apoA-I; human]) is a novel formulation of apoA-I in development for reduction of early recurrent cardiovascular events after acute myocardial infarction. Cholesterol efflux capacity (CEC) is a marker of high-density lipoprotein (HDL) function that is strongly...
Na minha lista:
| Publicado no: | Arterioscler Thromb Vasc Biol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5895137/ https://ncbi.nlm.nih.gov/pubmed/29437574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.118.310538 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|